• LinkedIn
  • Twitter
Vesigen Therapeutics
  • About
    • Company Overview
    • Team
    • Investors
  • Our Science
  • Programs
  • News
  • Careers
  • Contact
  • Menu Menu
  • About
    • Company Overview
    • Team
    • Investors
  • Our Science
  • Programs
  • News
  • Careers
  • Contact

News

Stay updated on Vesigen innovations

Press Release

Vesigen Highlights Therapeutic Platform for Non-Viral Delivery of Gene Editors and RNA at ASGCT 2023

CAMBRIDGE, Mass., May 22, 2023 /Business Wire/ — Vesigen Therapeutics, Inc., a biotechnology company developing a novel non-viral delivery platform ...
Press Release

Vesigen Therapeutics Announces Presentations at the American Society of Gene and Cell Therapy 26th Annual Meeting

CAMBRIDGE, Mass., May 2, 2023 /Business Wire/ -- Vesigen Therapeutics, Inc., a biotechnology company developing a novel non-viral delivery platform ...
Press Release

Vesigen Therapeutics Awarded Grant from Friedreich’s Ataxia Research Alliance (FARA) to Develop a Targeted Genome Editing Therapeutic Strategy

CAMBRIDGE, Mass., March 14, 2023 /Business Wire/ -- Vesigen Therapeutics, Inc., a biotechnology company developing targeted therapies by engineering a ...
Press Release

Vesigen Therapeutics, Inc. Announces Expansion of Scientific Advisory Board

CAMBRIDGE, Mass., February 7, 2023 /Business Wire/ -- Vesigen Therapeutics, Inc., a biotechnology company developing transformative therapeutics by engineering naturally ...
Press Release

Vesigen Therapeutics Names Rakhshita Dhar to Board of Directors

CAMBRIDGE, Mass., January 30, 2023 /Business Wire/ -- Vesigen Therapeutics, Inc., a biotechnology company developing transformative therapeutics by engineering naturally ...
Press Release

Vesigen Therapeutics Appoints Paulash Mohsen as Chief Executive Officer

CAMBRIDGE, Mass., Apr. 11, 2022 /Business Wire/ -- Vesigen Therapeutics, Inc., a biotechnology company pioneering a novel extracellular vesicle delivery ...
  • 1
  • 2
  • 3
  • ›
Loading...

Stay Connected

  • About
  • Our Science
  • Programs
  • News
  • Careers
  • Contact

Vesigen Therapeutics
790 Memorial Drive
Suite 103
Cambridge, MA 02139

LinkeInTwitter

© 2020 Vesigen Therapeutics
All rights reserved.
Privacy Policy
Terms of Use

Design and development by RainCastle Communications
Scroll to top
  • About
    • Company Overview
    • Team
    • Investors
  • Our Science
  • Programs
  • News
  • Careers
  • Contact